Influence of CPAP treatment on airway and systemic inflammation in OSAS patients

Sleep and Breathing

Volumn 18, Issue 2, 2014, Pages 251-256

  Karamanlı, Harun ^a   Özol, Duygu ^a   Ugur, K Serife ^a   Yıldırım, Zeki ^a   Armutçu, Ferah ^a   Bozkurt, Bulent ^a   Yigitoglu, Ramazan ^a  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

Author keywords

CPAP; Inflammation; Oxidative stress; Sleep apnea

Indexed keywords

3 NITROTYROSINE; 8 ISOPROSTANE; C REACTIVE PROTEIN; INTERLEUKIN 6; PEROXYNITRITE; TUMOR NECROSIS FACTOR ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; AUTACOID; PEROXYNITROUS ACID; PROSTAGLANDIN F2 ALPHA;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BLOOD SAMPLING; BREATHING; FEMALE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXIDATIVE STRESS; OXYGEN DESATURATION; PATIENT COMPLIANCE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SEDIMENTATION RATE; SLEEP DISORDERED BREATHING; SLEEP STAGE; SPIROMETRY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; IMMUNOLOGY; INFLAMMATION; METABOLISM; PROSPECTIVE STUDY; SLEEP APNEA, OBSTRUCTIVE;

ADULT; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; DINOPROST; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; PEROXYNITROUS ACID; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84900872438     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-012-0761-8     Document Type: Article

References (29)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230-1235
2. Kohler M, Stradling JR (2010) Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 7:677-685
3. Ryan S, Taylor CT, McNicholas WT (2009) Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Postgrad Med J 85:693-698
4. Quercioli A, Mach F, Montecucco F (2010) Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). Sleep Breath 14:261-269
5. Takama N, Kurabayasi M (2009) Influence of untreated sleep-disordered breathing on the long-term prognosis of patients with cardiovascular disease. Am J Cardiol 103:730-734
6. Foresi A, Leone C, Olivieri D, Cremona G (2007) Alveolarderived exhaled nitric oxide is reduced in obstructive sleep apnea syndrome. Chest 132:860-867
7. Alberti A, Sarchielli P, Gallinella E, Floridi A, Floridi A, Mazzotta G, Gallai V (2003) Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study. J Sleep Res 12:305-311
8. Ciftci TU, Kokturk O, Bukan N, Bilgihan A (2004) Relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 21:87-91
9. Kushida CA, Littner MR, Hirshkowitz M, Morgenthaler TI, Alessi CA, Bailey D, Boehlecke B, Brown TM, Coleman J Jr, Friedman L, Kapen S, Kapur VK, Kramer M, Lee-Chiong T, Owens J, Pancer JP, Swick TJ, Wise MS (2006) American Academy of Sleep Medicine Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 29:375-380
10. Kushida CA, Morgenthaler TI, Littner MR, Alessi CA, Bailey D, Coleman J Jr, Friedman L, Hirshkowitz M, Kapen S, Kramer M, Lee-Chiong T, Owens J, Pancer JP (2006) American Academy of Sleep Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances. Sleep 29:240-243
11. Skoczyński S, Ograbek-Król M, Tazbirek M, Semik-Orzech A, Pierzchała W (2008) Short-term CPAP treatment induces a mild increase in inflammatory cells in patients with sleep apnoea syndrome. Rhinology 46:144-150
12. Kohler M, Ayers L, Pepperell JC, Packwood KL, Ferry B, Crosthwaite N, Craig S, Siccoli MM, Davies RJ, Stradling JR (2009) Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax 64:67-73
13. Fortuna AM, Miralda R, Calaf N, González M, Casan P, Mayos M (2011) Airway and alveolar nitric oxide measurements in obstructive sleep apnea syndrome. Respir Med 105:630-636
14. Tamaki S, Yamauchi M, Fukuoka A, Makinodan K, Koyama N, Tomoda K, Yoshikawa M, Kimura H (2007) Production of inflammatory mediators by monocytes in patients with obstructive sleep apnea syndrome. Intern Med 48:1255 -1262
15. Iber C, Ancoli-Israel S, Chesson A, Quan SF (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology, and technical specification. 1st ed. American Academy of Sleep Medicine, Westchester
16. McNicholas WT (2009) Obstructive sleep apnea and inflammation. Prog Cardiovasc Dis 51:392-399
17. Salerno FG, Carpagnano E, Guido P, Bonsignore MR, Roberti A, Aliani M, Vignola AM, Spanevello A (2004) Airway inflammation in patients affected by obstructive sleep apnea syndrome. Respir Med 98:25
18. Guasti L, Marino F, Cosentino M, Maroni L, Maresca AM, Colombo F, Maio RC, Castiglioni L, Saporiti F, Loraschi A, Gaudio G, Bernasconi A, Laurita E, Grandi AM, Venco A (2011) Cytokine production from peripheral blood mononuclear cells and polymorphonuclear leukocytes in patients studied for suspected obstructive sleep apnea. Sleep Breath 15:3-11
19. Devouassoux G, Lévy P, Rossini E, Pin I, Fior-Gozlan M, Henry M, Seigneurin D, Pépin JL (2007) Sleep apnoea is associated with bronchial inflammation and continuous positive airway pressureinduced airway hyperresponsiveness. J Allergy Clin Immunol 119:597-603
20. Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Collins B, Basta M, Pejovic S, Chrousos GP (2008) Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest 38:585-595
21. Mota PC, Drummond M, Winck JC, Santos AC, Almeida J, Marques JA (2011) APAP impact on metabolic syndrome in obstructive sleep apnea patients. Sleep Breath 15:665-672
22. Hegglin A, Schoch OD, Korte W, Hahn K, Hürny C, Münzer T (2012) Eight months of continuous positive airway pressure (CPAP) decrease tumor necrosis factor alpha (TNFA) in men with obstructive sleep apnea syndrome. Sleep Breath 16:405-412
23. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107:1129-1134
24. Carpagnano GE, Spanevello A, Sabato R, Depalo A, Turchiarelli V, Foschino MP (2008) Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome. Transl Res 151:45-50
25. Weaver TE, Maislin G, Dinges DF, Bloxham T, George CF, Greenberg H, Kader G, Mahowald M, Younger J, Pack AI (2007) Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 30:711-719
26. Hunt J (2007) Exhaled breath condensate: an overview. Immunol Allergy Clin North Am 27:587-596
27. Rosias PP, Robroeks CM, Kester A, den Hartog GJ, Wodzig WK, Rijkers GT, Zimmermann LJ, van Schayck CP, Jöbsis Q, Dompeling E (2008) Biomarker reproducibility in exhaled breath condensate collected with different condensers. Eur Respir J 31:934-942
28. Yamauchi M, Kimura H (2008) Oxidative stress in obstructive sleep apnea: putative pathways to the cardiovascular complication. Antioxid Redox Signal 10:735-768
29. Petrosyan M, Perraki E, Simoes D, Koutsourelakis I, Vagiakis E, Roussos C, Gratziou C (2008) Exhaled breath markers in patients with obstructive sleep apnea. Sleep Breath 12:207-215